MedPath

Comparative study between effects of insulin degludec and glargine U300 on nighttime blood glucose fluctuation -Investigasion using flash glucose monitoring system

Phase 4
Conditions
diabetes mellitus
Registration Number
JPRN-UMIN000026829
Lead Sponsor
Fukuiken Saisekai Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1 Patients with a clear history of ischemic heart disease (angina, myocardial infarction), ischemic cerebrovascular disease 2 Patients with HbA1c fluctuating by 2% or more within 3 months 3 Severe ketosis, diabetic coma or prematurity 4 Patients with severe infection, preoperative, severe trauma 5 Cases judged by other physicians to be ineligible

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
For the first 5 days and last 5 days in the midnight to 6AM time zone 1 mean blood sugar level 2 Standard Deviation 3 Mean amplitude of glucose excursion
Secondary Outcome Measures
NameTimeMethod
For the first 5 days and last 5 days in the midnight to 6 AM time zone 1 Percentage of time zone with blood glucose level less than 70 mg per dl and its AUC 2 Percentage of time zone with blood sugar level less than 50 mg per dl and its AUC 3 Percentage of time zone with blood glucose level 140 mg per dl and its AUC
© Copyright 2025. All Rights Reserved by MedPath